Valiant Organics Ltd
Valiant Organics is engaged in the business of Manufacturing of chemicals for Agro Intermediate and Pharma.
- Market Cap ₹ 1,632 Cr.
- Current Price ₹ 601
- High / Low ₹ 869 / 355
- Stock P/E 22.7
- Book Value ₹ 245
- Dividend Yield 0.58 %
- ROCE 11.7 %
- ROE 11.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 17.7%
- Company's median sales growth is 25.1% of last 10 years
Cons
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -9.36%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
33 | 34 | 43 | 59 | 52 | 73 | 121 | 606 | 584 | 574 | 948 | 912 | |
26 | 28 | 34 | 48 | 36 | 55 | 94 | 426 | 410 | 417 | 783 | 782 | |
Operating Profit | 7 | 6 | 8 | 11 | 16 | 18 | 26 | 179 | 174 | 157 | 165 | 130 |
OPM % | 20% | 18% | 19% | 19% | 30% | 25% | 22% | 30% | 30% | 27% | 17% | 14% |
1 | 1 | 1 | 1 | 1 | 2 | 1 | 5 | 5 | 17 | 6 | 8 | |
Interest | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 2 | 1 | 3 | 6 | 11 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 12 | 13 | 19 | 27 | 28 |
Profit before tax | 6 | 6 | 8 | 11 | 16 | 18 | 25 | 171 | 165 | 152 | 137 | 100 |
Tax % | 34% | 34% | 32% | 34% | 35% | 35% | 35% | 29% | 25% | 25% | 25% | 24% |
Net Profit | 4 | 4 | 6 | 7 | 10 | 12 | 16 | 121 | 124 | 115 | 103 | 76 |
EPS in Rs | 43.56 | 57.57 | 79.14 | 103.86 | 14.03 | 15.92 | 13.97 | 103.65 | 51.00 | 42.20 | 37.91 | 27.83 |
Dividend Payout % | 27% | 38% | 27% | 50% | 71% | 16% | 23% | 6% | 11% | 12% | 9% | 4% |
Compounded Sales Growth | |
---|---|
10 Years: | 39% |
5 Years: | 50% |
3 Years: | 16% |
TTM: | -4% |
Compounded Profit Growth | |
---|---|
10 Years: | 33% |
5 Years: | 35% |
3 Years: | -17% |
TTM: | -30% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | -4% |
1 Year: | -13% |
Return on Equity | |
---|---|
10 Years: | 26% |
5 Years: | 25% |
3 Years: | 18% |
Last Year: | 11% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 0 | 0 | 0 | 4 | 6 | 6 | 6 | 14 | 28 | 28 | 27 | |
Reserves | 15 | 15 | 18 | 21 | 19 | 42 | 53 | 254 | 374 | 475 | 576 | 639 |
2 | 2 | 5 | 8 | 1 | 1 | 1 | 53 | 117 | 149 | 305 | 220 | |
9 | 10 | 14 | 11 | 17 | 23 | 36 | 89 | 127 | 154 | 175 | 220 | |
Total Liabilities | 26 | 28 | 37 | 40 | 41 | 69 | 96 | 402 | 629 | 806 | 1,083 | 1,106 |
10 | 10 | 11 | 11 | 12 | 26 | 31 | 130 | 256 | 478 | 509 | 610 | |
CWIP | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 66 | 129 | 46 | 110 | 70 |
Investments | 0 | 2 | 2 | 2 | 2 | 7 | 7 | 20 | 34 | 42 | 53 | 49 |
16 | 15 | 24 | 26 | 26 | 35 | 58 | 187 | 210 | 240 | 410 | 377 | |
Total Assets | 26 | 28 | 37 | 40 | 41 | 69 | 96 | 402 | 629 | 806 | 1,083 | 1,106 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | 8 | 3 | 6 | 18 | 9 | 18 | 77 | 160 | 115 | -11 | 182 | |
-1 | -3 | -2 | -1 | -1 | -1 | -6 | -88 | -191 | -135 | -120 | -90 | |
-2 | -5 | -2 | -5 | -16 | -4 | -5 | 2 | 35 | 22 | 146 | -108 | |
Net Cash Flow | 0 | -0 | -2 | -0 | 0 | 4 | 7 | -8 | 5 | 1 | 14 | -17 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 69 | 71 | 90 | 74 | 71 | 88 | 112 | 73 | 69 | 74 | 97 | 85 |
Inventory Days | 65 | 45 | 94 | 42 | 36 | 97 | 44 | 45 | 47 | 85 | 58 | 69 |
Days Payable | 55 | 91 | 81 | 7 | 50 | 130 | 154 | 80 | 97 | 135 | 76 | 100 |
Cash Conversion Cycle | 80 | 25 | 103 | 110 | 57 | 55 | 2 | 37 | 20 | 25 | 80 | 54 |
Working Capital Days | 77 | 5 | 44 | 101 | 66 | 70 | 42 | 55 | 34 | 51 | 90 | 68 |
ROCE % | 40% | 37% | 43% | 43% | 61% | 50% | 47% | 91% | 41% | 27% | 18% | 12% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
29 May - Secretarial Compliance Report for Financial Year ended March 31, 2023.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
24 May - Transcript of Earnings Call held on Monday, May 22, 2023.
- Audio Recording Of Q4 FY-23 Earnings Call 22 May
- Announcement under Regulation 30 (LODR)-Newspaper Publication 21 May
- Reappointment Of Auditors 20 May
Annual reports
Concalls
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Sep 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jul 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Mar 2022TranscriptNotesPPT
-
Mar 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Sep 2021TranscriptNotesPPT
Company Background
Valiant Organics Limited is a specialty chemical manufacturing company in India. The business was set up as a partnership concern (Valiant Chemical Corporation) in 1984. Key chemistries include Chlorination, Sulpho was converted into a public limited company in 2015. The Company’s head office is located in Mumbai. [1]